Tonlorenzi Rossana, Rossi Giuliana, Messina Graziella
INSPE (Institute of Experimental Neurology) San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milano, Italy.
Department of Biosciences, University of Milan, Via Celoria 26, 20133, Milan, Italy.
Methods Mol Biol. 2017;1556:149-177. doi: 10.1007/978-1-4939-6771-1_8.
More than 10 years ago, we isolated from mouse embryonic dorsal aorta a population of vessel-associated stem/progenitor cells, originally named mesoangioblasts (MABs ) , capable to differentiate in all mesodermal-derived tissues, including skeletal muscle. Similar though not identical cells have been later isolated and characterized from small vessels of adult mouse and human skeletal muscles. When delivered through the arterial circulation, MABs cross the blood vessel wall and participate in skeletal muscle regeneration , leading to an amelioration of muscular dystrophies in different preclinical animal models. As such, human MABs have been used under clinical-grade conditions for a Phase I/II clinical trial for Duchenne muscular dystrophy , just concluded. Although some pericyte markers can be used to identify mouse and human MABs , no single unequivocal marker can be used to isolate MABs . As a result, MABs are mainly defined by their isolation method and functional properties. This chapter provides detailed methods for isolation, culture, and characterization of MABs in light of the recent identification of a new marker, PW1 /Peg3, to screen and identify competent MABs before their use in cell therapy.
十多年前,我们从小鼠胚胎背主动脉中分离出一群与血管相关的干/祖细胞,最初命名为中血管平滑肌祖细胞(MABs),它们能够分化为所有中胚层来源的组织,包括骨骼肌。后来,人们从成年小鼠和人类骨骼肌的小血管中分离并鉴定出了类似但不完全相同的细胞。当通过动脉循环输送时,MABs穿过血管壁并参与骨骼肌再生,从而改善不同临床前动物模型中的肌肉营养不良症。因此,人源MABs已在临床级条件下用于杜氏肌营养不良症的I/II期临床试验,该试验刚刚结束。虽然一些周细胞标志物可用于鉴定小鼠和人源MABs,但没有单一明确的标志物可用于分离MABs。因此,MABs主要根据其分离方法和功能特性来定义。鉴于最近鉴定出一种新的标志物PW1/Peg3,本章提供了详细的方法,用于在MABs用于细胞治疗之前筛选和鉴定合格的MABs,以及对其进行分离、培养和表征。